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Distribution of Metallothionein-
Bound Cadmium and Cadmium
Chloride in Mice: Preliminary
Studies
by Monica Nordberg* and Gunnar F. Nordberg*
Metallothionein from livers ofmice was isolated by gel chromatography and isoelectric
focusing. One oftwo forms thus obtained contained 32% cysteine. This form, labeled in vitro
with l09Cd, was injected intravenously in mice, and the distribution of l09Cd was studied.
Animals killed after 4 hrs had over 80% of the injected dose in the kidneys. Protein ob-
tained after gel chromatography, containing both forms ofcadmium-binding protein, was
also labeled in vitro with lO9Cd and injected intravenously. Animals killed 4 hrs after injec-
tion had 50% of the injected dose in the kidneys. Whole-body measurements and whole-
body autoradiography demonstrated that approximately 40-60% of the injected dose had
been excreted in urine. The results show a selective accumulation of metallothionein-
bound cadmium in the kidney and indicate possible differences in distribution and excre-
tion of cadmium depending on binding to different forms of low molecular weight cad-
mium-binding proteins.
Introduction
A low molecular weight protein with an
unusually high content of cysteine was first
reported by Margoshes and Vallee (1). Kagi and
Vallee (2) published further data on this protein, at
which time they gave it the name, metallothionein.
A subsequent finding was that cadmium induced
the synthesis of this protein (3).
The metabolic role of metallothionein is still
under discussion (4), one suggestion being that it
acts as a detoxifying agent for cadmium (5). In
animal experiments, this role has been appeared to
involve on the one hand a protective effect against
testicular damage (6) and on the other hand a
damaging action upon the kidney (7). A theory has
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been advanced implying thatmetallothionein plays
a part in the redistribution of cadmium from the
liver to the kidney which occurs in long-term ex-
posure to cadmium (5).
The studies presented here were designed to
elucidate the fate of 109Cd-labeled metallothionein
when given intravenously. The study was per-
formed attwo laboratories and therefore somewhat
different techniques as well as two different mouse
strains were used.
Materials and Methods
Labeling of Metallothionein
Mouse liver metallothionein was prepared as
described by Nordberg, Nordberg, and Piscator (8).
The protein, obtained after ultracentrifugation and
chromatography on G-75 and G-50 Sephadex but
not further purified, was designated cadmium-
binding protein (Cd-BP).
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focusing revealed two main components. One con-
tained 61% of the total cadmium and very little
zinc, and had a pI of approximately 4 (identical
with the cadmium-metallothionein form 1 to be
described below). Another contained 24% of the
total cadmium and the main part of the zinc that
was present in the preparation. This component
had a pl of approximately 6.
Isoelectric focusing was also employed for
further purification of metallothionein. In order to
optimize the output of purified protein, fractions
corresponding to a pH-interval of 3.9-4.2 were
pooled and deampholytized. The protein thus ob-
tained was designated metallothionein form 1 (Cd-
MT1). Characterization by amino acid analysis
gave onlyminor differences from earlier findings by
Nordberg, Nordberg, and, Piscator (8). A high
purity of the present metallothionein (Cd-MT1)
was indicated by the high content of cysteine (32
residues - % ) and the absence of aromatic amino
acids. The metal content of lyophilized Cd-MT1
was 10% Cd (w/w) and approximately 0.4% Zn
(w/w). The E250/E28o ratio was 17. The labeling of
Cd-BP and Cd-MT1 was performed in the same
way. The respective proteins were exposed to l09Cd
in vitro in an aqueous medium containing
Tris-NaCl (Tris buffer 0.01M in 0.05M NaCl, pH
8.0, for the Cd-BP; Tris buffer p.AM in 0.5M NaCl,
pH 8.0, for Cd-MT1). That all l09Cd had been
bound to the protein and that virtually no free cad-
mium remained were checked by chromatography
on G-50 and G-75 Sephadex (Figs. 1 and 2O. The
radioactive cadmium peak appeared at the same
elution volume as has the nonradioactive
metallothionein cadmium peak earlier.
FIGURE 1. G-50 Sephadex chromatography of a sample of
1"9CdBP. Column dimensions 885 x 25 mm. Elution with
0.01.M Tris buffer - 0.05M NaCl, pH 8.0, + 8°C. Fractions of
5 ml were collected at 28 ml/hr. Recovery of Cd, 98%.
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FIGURE 2. G-75 Sephadex chromatography of 109CdMT-1. Col-
umn dimensions, 365 x 25 mm. Elution with 0.1M Tris
buffer - 0.5M NaCl, pH 8.0, + 4°C. Fractions of 5 ml were
collected at 14 ml/hr. Fractions 21-31 indicated by the bold
line were concentrated, buffer concentration and pH ad-
justed to physiological values (0.9% NaCl, pH 7.2), and in-
jected intravenously in mice. Recovery of Cd, 98%.
Animals
Twenty-five male C57BL16JH (J67) mice
were obtained from the Jackson Laboratory, Bar
Harbor, Maine 04609, U.S.A. The mice, which had
body weights of 25-33 g, were divided into two
groups for studies on 109Cd-MT1 and 1O9CdCl2 in
comparable doses (Table 1).
Twenty male CBA-mice from the Institute of
Genetics, University of Stockholm, Sweden, with
body weights of 20.0-25.3 g, were divided into two
groups and used for studies on 109Cd-BP and
parallel injections of 1O9CdCl2 (Table 2).
Treatment of Animals
All animals were given a single intravenous in-
jection in a tail vein. Fourteen C57BL mice were
given l19Cd-MT1, and eleven such mice were given
the same doses of cadmium as radiolabeled CdCl2.
Subdivision of animals in two dose groups (0.03
and 0.08 mg Cd/kg) is seen in Table 1. In order to
collect urine from mice with 4 hr survival time the
animals were put in metabolism cages during the
interval between injection and killing. Animals
were killed after 5 min or 4 hr by heart puncture
and cervical dislocation. Organs were removed and
weights recorded. Cadmium content was cal-
culated from values obtained by gamma counting
of the organs (6).
Environmental Health Perspectives 104Table 1. Amount of '"9Cd found in kidney and liver in mice injected intravenously with 109Cd-MT1, 109Cd-BP,
and 109CdCl2.
lO9Cd in kidneys, % ofdosea l09Cd in liver, % ofdosea
Timne 109Cd-MT1 109Cd-BP, 109CdCl2 109Cd-MT1 o0Cd-BP, L 19CdCI2 after
injection L H I L H I L H I L H I
5 min 45.0 43.5 30.8 2.9 2.5 3.9 4.8 27.4
31.8 32.3 34.4 2.3 3.1 3.2 3.2 2.7 5.6 12.7 20.8 32.8
39.0 38.9 2.3 4.0 3.2 5.8 2.8 19.3 23.8 40.8
Mean 38.6 38.2 32.6 2.5 3.6 3.2 3.8 3.1 5.2 19.8 22.3 36.8
4 hr 82.1 76.8 10.7 6.5 4.9 4.2 8.2 56.0 55.5 68.5
93.4 89.5 43.7 5.8 6.6 4.6 10.6 8.9 4.3 48.6 56.0 60.8
107.0 84.0 56.4 5.0 6.7 10.6 7.3 4.8 44.9 62.8
99.1 73.6 7.0 5.1
Mean 95.4 81.0 50.1 7.2 6.6 4.8 8.1 7.4 4.6 49.8 58.1 64.7
'Dose levels: L = low dose = 0.03 mgCd/kg; H = highdose = 0.08 mgCd/kg; I = intermediate dose = 0.075 mg Cd/kg.
Table 2. Body burden and concentration ofcadmium in kidney and liver of mice injected intravenously with '"Cd-bind-
ing protein ('"9Cd-BP) and 109CdCI2.
IT9Cd from injection Body burden, u.g Cd/whole body Cd, ,ug/g wet tissue
compound to killing After injection Just before killing Kidney Liver
109Cd-BP 2 min 1.5 0.88 0.10
5 min 1.5 1.54 0.06
6 min 1.5 1.72 0.07
20 min 1.6 1.08 0.05
20 min 1.3 1.3 1.97 0.05
4 hr 1.4 1.oa 2.04 0.06
4 hr 1.5 0.8b 2.82 0.10
24 hr 1.5 0.8 2.18 0.09
96 hr 1.6 0.6 2.17 0.09
96 hr 1.7 0.6 2.52 0.09
1O9CdCl2 1 min 1.4 0.19 0.34
5min 1.5 0.16 0.51
5 min 1.5 0.16 0.41
20min 1.5 0.20 0.68
20 min 1.7 1.7 0.16 0.80
4 hr 1.7 1.9 0.28 0.97
4 hr 1.5 1.6 0.23 0.76
24 hr 1.4 1.4 0.24 0.79
96 hr 1.7 1.6 0.25 0.99
96 hr 1.6 1.3 0.25 0.84
'0.4,ag measured in urine (and feces) collected immediately prior to whole body counting.
b<0.0001Ag measured in feces collected immediatelyprior to whole bodycounting.
Ten CBA-mice were given Cd-BP and ten mice
were given radioactive cadmium as CdCl2. Each
animal was given approximately 1.6 ,tg Cd and 0.4
jig Zn, corresponding to a dose of 0.075 mg Cd/kg
body weight and 0.02 mg Zn/kg body weight. The
cadmium/zinc ratio is the same as in the Cd-BP.
One or two animals were killed after 1, 5, and 20
min and 24 and 96 hr (Table 2). After injection and
just before killing all animals were subjected to
whole-body counting.
Other Methods
Autoradiography was performed on the animals
treated with 109Cd-BP and the corresponding ones
injected with 109CdCl2. The method was described
by Ullberg (11 ). In the main, sections of the frozen
mouse were prepared at 20 j,m on a tape and ap-
posed to Structurix or Kodirex X-ray film.
Scintillation counting of organs removed from
the thawed corpses of the mice (after sectioning)
December 1975 105was performed in a gamma counter as described by
Nordberg (6).
Results and Discussion
Scintillation Counting
Table 1 gives the amounts of cadmium found in
liver and kidney after injection of 109Cd-MT1. After
5 min, 38.6% (mean) of the total injected dose has
already accumulated in the kidney in the lower
dose group. The corresponding figure for the higher
dose group was almost the same (38.2% ). By 4 hr
after the injection, the animals given the lower dose
had an average of 95.4% of the total injected dose
in the kidneys, and the corresponding figure for the
higher dose was 81%.
In some cases more than 100% of the injected
dose were recovered in liver and kidney, par-
ticularly in the lower dose group. Indeed, an error
ofthe order 20% may easily arise and be explained
by the small volume of solution injected (0.05 ml),
since the syringe was graduated in 0.01 ml units. In
the higher dose group, larger volumes (0.15 ml)
were used, the relative error upon injection
therefore being smaller.
It is further evident from Table 1 that more than
10 times as much cadmium was accumulated in the
kidneys when the cadmium was injected as Cd-
MT1 than as CdCl2; liver values, on the other
hand, were lower.
Values for animals injected with Cd-BP and
with survival times corresponding to those in the
Cd-MTI study are also given in Table 1. In these
animals approximately 10-fold larger amounts of
cadmium were found in kidneys than with the cor-
responding CdCl2 animals.
A direct comparison of Cd-BP animals with
CdMT1 ones is obviously somewhat limited
because different strains of mice were used for the
two studies. It might be appropriate to point out,
however, that the renal accumulation expressed as
per cent ofinjected dose in Cd-MT1 animals (81% )
seems higher than when approximately the same
dose of cadmium was injected as Cd-BP (50% ).
This observation was further supported by the
whole body measurements in Table 2. Whereas a
very minor tendency, i.e., approximately 10%,
towards a decrease arose in CdCl2 animals during
the 96 hr, the whole body values ofthe Cd-BP mice
decreased by approximately 40-60% by 4- 96 hr
after injection.
Urine values for the CdMT1 injected mice (4-hr
survival time) showed a broad range for the lower
dose group. Theyvaried from 0.03-1.23% ofthe in-
jected dose. In the higher dose group, correspond-
ing values were 0.03-2.18% of the injected dose.
For the Cd-BP injected mice some occasional ex-
cretion values were also obtained. One 4-hr mouse
excreted 0.4 ,ug (24% ) of cadmium in urine and
feces. The second 4-hr mouse excreted less than
0.0001 jig Cd in feces during the same time inter-
val. Urine was not collected. From this it seems
most likely that the cadmium has been excreted via
urine. This also indicates a difference in Cd-excre-
tion of the two protein forms Cd-MT1 and Cd-BP.
The mice injected with 1O9CdCl2 had a low excre-
tion of cadmium in the urine and the values (4 hr)
ranged from 0.02 to 0.08% of the injected dose.
Autoradiography
Distribution among Organs: The general dis-
tribution pattern ofinjected l09CdCla was the same
as that reported by Berlin and Ullberg (9) and
Nordberg and Nishiyama (10) withthe highest con-
centration in the liver and somewhat lower con-
centrations in pancreas and kidney at the survival
times employed (2 min-1 day).
A markedly ditterent pattern mace itsent eviaent
in autoradiograms from animals injected with
109Cd-BP. By 2 min after injection, substantial up-
take ofcadmium in the renal tissue had already oc-
curred, this organ standing out with considerable
blackening against a very pale background repre-
senting other tissues. Blackening of an intensity
similar to the one corresponding to the kidney was
also seen to represent the contents of the urinary
bladder in 20-min animals, but not in animals hav-
ing shorter or longer survival times. The difference
in the distribution patterns between CdCl2 mice
and Cd-BP mice is illustrated in Figure 3.
Distribution within the Kidneys: Auto-
radiographic studies employing the whole body sec-
tioning technique also enable determination ofdis-
tribution among various structures within organs
(9, 11). In the present study the distribution within
the kidney is of particular interest. In
autoradiograms from animals injected with
109CdCl2, the distribution pattern in the kidney was
in accord with that reported previously (9, 10, 12),
i.e., a maximum spotwise darkening in the outer
zone of the kidney cortex, probably corresponding
to the most proximal tubule. Atvariance with what
was reported by Berlin and Ullberg (9), the present
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times represents an excretion of cadmium into the
urine. Autoradiograms from longer times after in-
jection showed most of the cadmium retained in
these 109Cd-BP-injected mice to be confined to the
kidney cortex (Fig. 4). The spotwise appearance of
the blackening in the outer cortex ofthese animals
is similar to the pattern unfolded (12) for cadmium
chloride injected mice and shown to correspond to
an uptake in the first part of the proximal tubule.
More detailed studies are warranted in order to
define more precisely the localization of
metallothionein-bound cadmium.
FIGURE 3. Whole-body autoradiograms of mice. (Top) 20 min
after a single intravenous injection with 109CdCl2. Darkened
parts correspond to high accumulation of cadmium. The
highest Cd-concentration is seen in the liver. (Bottom) 20
min after a single intravenous injection with 109Cd-BP. Ac-
cumulation is seen in the kidney and urine in the urinary
bladder.
autoradiograms demonstrated that the darkening
in the renal cortex, even at the darkest spots, never
exceeded the darkening of the liver during the
shortertimes after injection. This maybe explained
bythe highest doses ofcadmium used in this study,
since it is known (5) that a smaller proportion of
cadmium will be found in the kidney ofexperimen-
tal animals given larger doses.
The whole body countings (Table 2) show that
the amount of cadmium retained in the group in-
jected with 1O9CdCl2 was approximately constant,
while appreciable excretion of cadmium occurred
already between 20 min and 4 hr in mice injected
with 109Cd-BP. This suggests that the blackening in
the central parts of the kidney observed in
FIGURE 4. Detail (kidney) of whole-body autoradiogram from
a mouse intravenously injected with 109CdBP and killed
after 4 hr.
In summary, the present results show that, once
it has reached the blood, metallothionein-bound
cadmium is transported to the kidney where it ac-
cumulates selectively. This supports our previously
advanced theory pointing to an involvement of
metallothionein in the redistribution of cadmium
from liver to kidney in long-term exposure and a
role of this protein in the elicitation of renal tubu-
lar effects of cadmium.
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